MOXIFLOXACIN HYDROCHLORIDE

MOXIFLOXACIN HYDROCHLORIDE was reported 20741 times

MOXIFLOXACIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIS TRANSILLUMINATION DEFECT 118 0.6310
1 TOTAL LUNG CAPACITY INCREASED 154 0.5662
2 SPIROMETRY ABNORMAL 298 0.4983
3 MITE ALLERGY 280 0.4275
4 MYCOTIC ALLERGY 283 0.3310
5 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 158 0.3021
6 PULMONARY VASCULITIS 160 0.2974
7 DUST ALLERGY 286 0.2915
8 TOTAL LUNG CAPACITY ABNORMAL 111 0.2853
9 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 29 0.2762
10 IRIS HYPOPIGMENTATION 27 0.2523
11 CHOROIDITIS 93 0.2487
12 KERATITIS FUNGAL 49 0.2356
13 CAPILLARITIS 64 0.2319
14 MYCOBACTERIAL PERITONITIS 21 0.2211
15 TENDER JOINT COUNT 17 0.2024
16 TYPE 2 LEPRA REACTION 37 0.1979
17 CONJUNCTIVITIS ALLERGIC 291 0.1964
18 PERSISTENT CORNEAL EPITHELIAL DEFECT 20 0.1695
19 TOXIC ANTERIOR SEGMENT SYNDROME 173 0.1586
20 CORNEAL INFILTRATES 48 0.1529
21 C-REACTIVE PROTEIN 141 0.1521
22 MYCOBACTERIUM FORTUITUM INFECTION 27 0.1459
23 NASAL OEDEMA 249 0.1377
24 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 98 0.1337
25 TEMPERATURE REGULATION DISORDER 292 0.1309
26 SWOLLEN JOINT COUNT 31 0.1240
27 KERATITIS BACTERIAL 20 0.1227
28 GRIP STRENGTH 28 0.1223
29 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 20 0.1099
30 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 28 0.1033
31 IRIS ATROPHY 21 0.1014
32 HYPOPYON 84 0.1014
33 DEEP VEIN THROMBOSIS POSTOPERATIVE 203 0.1013
34 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 22 0.0995
35 NEURITIS 151 0.0977
36 NORMOCHROMIC NORMOCYTIC ANAEMIA 287 0.0954
37 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 31 0.0925
38 CORNEAL EPITHELIUM DEFECT 53 0.0912
39 SPUTUM PURULENT 56 0.0851
40 MYCOBACTERIUM ABSCESSUS INFECTION 60 0.0839
41 CONTRAST MEDIA ALLERGY 146 0.0797
42 X-RAY ABNORMAL 142 0.0793
43 CORNEAL PERFORATION 50 0.0792
44 ANTERIOR CHAMBER CELL 54 0.0756
45 ANTICIPATORY ANXIETY 20 0.0735
46 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 40 0.0713
47 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 144 0.0706
48 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 47 0.0704
49 FACET JOINT SYNDROME 220 0.0675
50 EYE INFECTION FUNGAL 26 0.0672
51 CORNEAL OEDEMA 147 0.0655
52 SWOLLEN JOINT COUNT INCREASED 206 0.0645
53 OESOPHAGEAL SPASM 115 0.0624
54 RESPIRATORY SYMPTOM 169 0.0594
55 OBLITERATIVE BRONCHIOLITIS 76 0.0579
56 FOETAL DEATH 290 0.0559
57 PERIORBITAL PAIN 47 0.0555
58 FOOD ALLERGY 427 0.0553
59 BREAST CONSERVING SURGERY 28 0.0547
60 PERIPHERAL VENOUS DISEASE 216 0.0528
61 FORCED EXPIRATORY VOLUME DECREASED 148 0.0522
62 LUPUS VULGARIS 65 0.0516
63 RHEUMATIC FEVER 230 0.0515
64 BLOOD IMMUNOGLOBULIN M INCREASED 31 0.0510
65 BLOOD IMMUNOGLOBULIN A DECREASED 33 0.0507
66 ENDOPHTHALMITIS 298 0.0496
67 CORYNEBACTERIUM INFECTION 26 0.0486
68 CORNEAL DEPOSITS 36 0.0484
69 RETINITIS 83 0.0480
70 TOXIC OPTIC NEUROPATHY 20 0.0461
71 DYSBIOSIS 36 0.0438
72 CORNEAL SCAR 22 0.0437
73 ANTERIOR CHAMBER INFLAMMATION 26 0.0437
74 C-REACTIVE PROTEIN ABNORMAL 280 0.0436
75 RESPIRATORY GAS EXCHANGE DISORDER 16 0.0431
76 ULCERATIVE KERATITIS 114 0.0416
77 SECONDARY IMMUNODEFICIENCY 50 0.0412
78 PORPHYRIA ACUTE 59 0.0411
79 TENDON DISCOMFORT 31 0.0411
80 OTOTOXICITY 76 0.0411
81 MYCOBACTERIUM CHELONAE INFECTION 30 0.0406
82 MYCOBACTERIAL INFECTION 67 0.0389
83 RHINITIS ALLERGIC 171 0.0384
84 HYPOTONY OF EYE 16 0.0381
85 CORNEAL OPACITY 50 0.0366
86 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 236 0.0363
87 BURSITIS 440 0.0362
88 ARTERIOSCLEROSIS CORONARY ARTERY 233 0.0351
89 PARADOXICAL DRUG REACTION 129 0.0350
90 ACINETOBACTER INFECTION 38 0.0347
91 MYCOBACTERIUM AVIUM COMPLEX INFECTION 93 0.0346
92 CORNEAL TRANSPLANT 27 0.0345
93 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 70 0.0338
94 SARCOIDOSIS 160 0.0336
95 MUSCLE INJURY 277 0.0334
96 FULL BLOOD COUNT ABNORMAL 352 0.0332
97 PNEUMONIA HAEMOPHILUS 16 0.0329
98 RHEUMATOID FACTOR POSITIVE 189 0.0327
99 NASAL POLYPS 159 0.0323
100 LOSS OF EMPLOYMENT 94 0.0311
101 VITREOUS OPACITIES 26 0.0308
102 EYELID PAIN 62 0.0305
103 IMMUNODEFICIENCY 454 0.0304
104 MENINGITIS TUBERCULOUS 17 0.0304
105 JAUNDICE CHOLESTATIC 107 0.0303
106 RETINAL ISCHAEMIA 18 0.0295
107 DUODENAL ULCER PERFORATION 218 0.0293
108 WHEEZING 1736 0.0292
109 VITRITIS 53 0.0286
110 OESOPHAGEAL PAIN 113 0.0286
111 PRESCRIBED OVERDOSE 552 0.0285
112 ARTERIOSCLEROSIS 267 0.0283
113 PUNCTATE KERATITIS 26 0.0283
114 PULMONARY ALVEOLAR HAEMORRHAGE 159 0.0283
115 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 202 0.0282
116 DISLOCATION OF VERTEBRA 64 0.0280
117 BRONCHIECTASIS 188 0.0279
118 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 466 0.0274
119 PSOAS ABSCESS 17 0.0273
120 OBSTRUCTIVE AIRWAYS DISORDER 302 0.0271
121 NEUROLOGICAL SYMPTOM 155 0.0271
122 THERAPEUTIC PRODUCT CROSS-REACTIVITY 24 0.0269
123 LUNG HYPERINFLATION 23 0.0267
124 HYPOMANIA 98 0.0266
125 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 28 0.0264
126 LYMPHOEDEMA 181 0.0261
127 PULMONARY CAVITATION 22 0.0253
128 COELIAC DISEASE 243 0.0247
129 NON-INFECTIOUS ENDOPHTHALMITIS 21 0.0247
130 BLOOD IMMUNOGLOBULIN G INCREASED 30 0.0247
131 LIP DRY 222 0.0244
132 HELICOBACTER INFECTION 245 0.0238
133 CORNEAL DISORDER 52 0.0237
134 FOLLICULITIS 248 0.0236
135 ATYPICAL MYCOBACTERIAL INFECTION 33 0.0233
136 NODULE 304 0.0233
137 OPTIC NEUROPATHY 49 0.0231
138 HILAR LYMPHADENOPATHY 20 0.0227
139 CORNEAL ABRASION 31 0.0226
140 OBSTRUCTIVE SLEEP APNOEA SYNDROME 32 0.0219
141 BRONCHITIS CHRONIC 53 0.0217
142 TACHYARRHYTHMIA 54 0.0216
143 CONTRAINDICATED PRODUCT ADMINISTERED 652 0.0215
144 BONE EROSION 76 0.0215
145 OEDEMA 1159 0.0213
146 MULTIPLE-DRUG RESISTANCE 65 0.0209
147 HAND DEFORMITY 273 0.0208
148 STENOTROPHOMONAS INFECTION 28 0.0206
149 OCULAR VASCULAR DISORDER 17 0.0206
150 AUTOIMMUNE DISORDER 201 0.0206
151 MATERNAL EXPOSURE TIMING UNSPECIFIED 77 0.0205
152 DRUG RESISTANCE 517 0.0201
153 KERATITIS 61 0.0200
154 RHEUMATOID LUNG 19 0.0199
155 PRURITUS ALLERGIC 23 0.0197
156 CARDIAC MURMUR 169 0.0195
157 PEMPHIGUS 243 0.0194
158 SYNOVITIS 348 0.0193
159 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 17 0.0191
160 ASTHMA 2159 0.0191
161 DISSEMINATED TUBERCULOSIS 48 0.0187
162 PRODUCT MONITORING ERROR 27 0.0187
163 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 92 0.0184
164 SUPERFICIAL INJURY OF EYE 20 0.0183
165 OBESITY 291 0.0182
166 RESPIRATORY TRACT INFECTION 470 0.0180
167 IRIDOCYCLITIS 56 0.0177
168 CONJUNCTIVAL OEDEMA 18 0.0175
169 CONJUNCTIVAL HYPERAEMIA 62 0.0174
170 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 40 0.0173
171 HYPERPARATHYROIDISM SECONDARY 43 0.0171
172 NEPHROGENIC ANAEMIA 79 0.0170
173 VASCULITIS 197 0.0169
174 NOCARDIOSIS 43 0.0168
175 FIBROMYALGIA 404 0.0166
176 SCIATICA 261 0.0164
177 RETINAL VASCULITIS 19 0.0160
178 FOREIGN BODY SENSATION IN EYES 101 0.0158
179 PRODUCT CLOSURE REMOVAL DIFFICULT 16 0.0157
180 RHEUMATIC DISORDER 30 0.0155
181 EYE PAIN 873 0.0155
182 PULMONARY FIBROSIS 292 0.0152
183 INTRAOCULAR PRESSURE INCREASED 191 0.0149
184 PERICARDITIS 248 0.0147
185 VESTIBULAR DISORDER 18 0.0147
186 BLOOD PRESSURE SYSTOLIC ABNORMAL 35 0.0141
187 ELECTROCARDIOGRAM QT PROLONGED 497 0.0138
188 LOWER LIMB FRACTURE 262 0.0136
189 EYE INFLAMMATION 130 0.0136
190 TORSADE DE POINTES 106 0.0135
191 UPPER RESPIRATORY TRACT INFECTION 623 0.0135
192 JOINT RANGE OF MOTION DECREASED 177 0.0132
193 HEPATIC ENZYME INCREASED 886 0.0130
194 SPUTUM INCREASED 28 0.0129
195 GLOSSODYNIA 287 0.0128
196 SPUTUM DISCOLOURED 121 0.0127
197 PULMONARY TUBERCULOSIS 53 0.0124
198 HEPATOTOXICITY 276 0.0124
199 OCULAR HYPERTENSION 24 0.0124
200 PATHOGEN RESISTANCE 112 0.0123
201 REBOUND ACID HYPERSECRETION 37 0.0122
202 CYSTOID MACULAR OEDEMA 23 0.0122
203 DRUG TOLERANCE DECREASED 34 0.0121
204 DRUG INTOLERANCE 1156 0.0120
205 SCLERITIS 19 0.0119
206 INFUSION RELATED REACTION 778 0.0117
207 LIVER INJURY 287 0.0117
208 DEAFNESS NEUROSENSORY 38 0.0115
209 PHOTOPHOBIA 217 0.0115
210 BRAIN ABSCESS 29 0.0114
211 PRODUCTIVE COUGH 546 0.0114
212 DISORGANISED SPEECH 21 0.0114
213 FEAR OF DISEASE 20 0.0112
214 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 284 0.0110
215 RED BLOOD CELL SEDIMENTATION RATE INCREASED 122 0.0110
216 RETINAL OEDEMA 21 0.0110
217 LUNG DISORDER 538 0.0110
218 LONG QT SYNDROME 26 0.0108
219 PUSTULAR PSORIASIS 37 0.0108
220 IRRITABLE BOWEL SYNDROME 230 0.0107
221 HYPOXIA 371 0.0105
222 RETINAL HAEMORRHAGE 75 0.0105
223 TREATMENT FAILURE 872 0.0105
224 WOUND 294 0.0105
225 LYMPHADENOPATHY MEDIASTINAL 20 0.0104
226 OCULAR DISCOMFORT 117 0.0104
227 FLUID RETENTION 527 0.0104
228 ENTEROCOCCAL INFECTION 50 0.0103
229 SINUS PAIN 24 0.0103
230 EXOSTOSIS 91 0.0100
231 UVEITIS 134 0.0099
232 IDIOPATHIC INTRACRANIAL HYPERTENSION 22 0.0098
233 HYPERLACTACIDAEMIA 26 0.0097
234 DRUG-INDUCED LIVER INJURY 304 0.0097
235 IMPAIRED HEALING 316 0.0096
236 TENDON PAIN 72 0.0095
237 RALES 55 0.0095
238 CATARACT OPERATION 56 0.0094
239 HYPERCHOLESTEROLAEMIA 90 0.0093
240 ACUTE MYELOID LEUKAEMIA RECURRENT 20 0.0093
241 VISUAL ACUITY REDUCED 309 0.0093
242 OBSTRUCTION 37 0.0093
243 LOWER RESPIRATORY TRACT INFECTION 420 0.0092
244 METAMORPHOPSIA 17 0.0092
245 CHEST INJURY 19 0.0092
246 HAEMOPTYSIS 256 0.0092
247 LUNG NEOPLASM 39 0.0091
248 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 68 0.0091
249 VITREOUS HAEMORRHAGE 25 0.0090
250 ASPERGILLUS INFECTION 59 0.0090
251 GRIP STRENGTH DECREASED 79 0.0090
252 LIVE BIRTH 75 0.0090
253 WOUND INFECTION 98 0.0089
254 EXPOSURE DURING PREGNANCY 550 0.0088
255 BREAST CANCER STAGE III 57 0.0088
256 HYPERTRANSAMINASAEMIA 61 0.0088
257 TENDONITIS 135 0.0087
258 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 416 0.0087
259 RASH MORBILLIFORM 24 0.0086
260 PNEUMONIA FUNGAL 34 0.0086
261 LIVER DISORDER 382 0.0086
262 HEPATIC STEATOSIS 158 0.0085
263 NIGHT SWEATS 273 0.0085
264 CARDIAC DISCOMFORT 17 0.0084
265 RADIATION PNEUMONITIS 18 0.0084
266 TYPE IV HYPERSENSITIVITY REACTION 23 0.0084
267 JOINT SWELLING 1002 0.0083
268 RASH ERYTHEMATOUS 396 0.0083
269 SWELLING OF EYELID 52 0.0083
270 RASH VESICULAR 40 0.0083
271 METASTATIC MALIGNANT MELANOMA 19 0.0083
272 LYMPHADENITIS 20 0.0083
273 BLOOD PRESSURE DIASTOLIC ABNORMAL 21 0.0082
274 SCHIZOPHRENIA 100 0.0082
275 LIMB MASS 18 0.0082
276 CONCOMITANT DISEASE PROGRESSION 16 0.0082
277 SLEEP APNOEA SYNDROME 155 0.0081
278 SYSTEMIC LUPUS ERYTHEMATOSUS 284 0.0080
279 LUPUS-LIKE SYNDROME 71 0.0078
280 RHEUMATOID ARTHRITIS 886 0.0078
281 EYE OEDEMA 19 0.0077
282 TENDON DISORDER 50 0.0077
283 VITREOUS FLOATERS 75 0.0076
284 TYPE 2 DIABETES MELLITUS 255 0.0076
285 CYSTITIS 241 0.0076
286 RETINAL ARTERY OCCLUSION 19 0.0075
287 VENTRICULAR HYPOKINESIA 24 0.0075
288 INCREASED BRONCHIAL SECRETION 19 0.0074
289 VITREOUS DETACHMENT 16 0.0074
290 HIP ARTHROPLASTY 113 0.0074
291 DECREASED IMMUNE RESPONSIVENESS 72 0.0073
292 HEPATITIS TOXIC 19 0.0073
293 OPTIC NEURITIS 66 0.0073
294 MUSCULOSKELETAL PAIN 380 0.0072
295 EYELID IRRITATION 18 0.0072
296 NEUROPATHY PERIPHERAL 681 0.0072
297 EYE DISCHARGE 74 0.0071
298 JOINT DISLOCATION 75 0.0071
299 THERAPEUTIC PRODUCT EFFECT DECREASED 316 0.0070
300 PAINFUL RESPIRATION 17 0.0070
301 PULMONARY MASS 104 0.0070
302 BLOOD CHLORIDE DECREASED 18 0.0070
303 END STAGE RENAL DISEASE 127 0.0070
304 MACULAR OEDEMA 39 0.0070
305 PSORIATIC ARTHROPATHY 282 0.0069
306 BREATH SOUNDS ABNORMAL 34 0.0069
307 OCULAR HYPERAEMIA 327 0.0069
308 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 490 0.0069
309 BLOOD IMMUNOGLOBULIN G DECREASED 17 0.0069
310 STOMATITIS 416 0.0069
311 FOOT DEFORMITY 76 0.0068
312 THROMBOCYTOPENIA 763 0.0068
313 TOXIC EPIDERMAL NECROLYSIS 103 0.0068
314 HYPOTHYROIDISM 215 0.0067
315 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 351 0.0067
316 VENTRICULAR ARRHYTHMIA 24 0.0066
317 LACRIMATION INCREASED 198 0.0065
318 EYE INFECTION 74 0.0065
319 RED BLOOD CELL COUNT INCREASED 18 0.0065
320 RETINAL DETACHMENT 60 0.0065
321 EYE IRRITATION 373 0.0065
322 LUNG CONSOLIDATION 18 0.0064
323 SUSPECTED OFF LABEL USE 29 0.0064
324 HEPATIC ENZYME ABNORMAL 32 0.0064
325 PNEUMONIA 2068 0.0064
326 COLITIS MICROSCOPIC 30 0.0063
327 OSTEOARTHRITIS 268 0.0063
328 PNEUMONIA VIRAL 20 0.0063
329 EMBOLISM VENOUS 19 0.0063
330 SUBCUTANEOUS ABSCESS 30 0.0063
331 EYE INJURY 19 0.0062
332 DEPRESSIVE SYMPTOM 22 0.0062
333 GAIT INABILITY 207 0.0062
334 TINNITUS 283 0.0062
335 MUCORMYCOSIS 16 0.0062
336 ERYTHEMA OF EYELID 33 0.0061
337 HYPERSENSITIVITY 1131 0.0061
338 WALKING AID USER 40 0.0061
339 ROAD TRAFFIC ACCIDENT 252 0.0060
340 THERAPY NON-RESPONDER 270 0.0060
341 BLEPHARITIS 24 0.0060
342 BLOOD BILIRUBIN INCREASED 161 0.0060
343 IRITIS 18 0.0059
344 NICOTINE DEPENDENCE 46 0.0059
345 BREAST CANCER STAGE II 49 0.0059
346 EOSINOPHIL COUNT INCREASED 49 0.0059
347 TENOSYNOVITIS 16 0.0058
348 FOETAL GROWTH RESTRICTION 35 0.0058
349 PREGNANCY 115 0.0057
350 KLEBSIELLA INFECTION 29 0.0057
351 ELECTRIC SHOCK SENSATION 16 0.0057
352 BLINDNESS UNILATERAL 80 0.0057
353 BRONCHITIS 418 0.0056
354 INFLAMMATION 286 0.0055
355 HYPOVENTILATION 18 0.0055
356 POLYNEUROPATHY 66 0.0055
357 ARTHROPATHY 306 0.0055
358 GENERAL SYMPTOM 41 0.0055
359 MULTIPLE ALLERGIES 42 0.0054
360 BLOOD CHOLESTEROL INCREASED 247 0.0053
361 BRONCHOPULMONARY ASPERGILLOSIS 41 0.0053
362 HYPERTENSION 1113 0.0052
363 EOSINOPHILIA 92 0.0052
364 GLAUCOMA 101 0.0052
365 GASTROINTESTINAL DISORDER 469 0.0052
366 HYPERHIDROSIS 672 0.0052
367 C-REACTIVE PROTEIN INCREASED 189 0.0052
368 PSYCHOTIC DISORDER 152 0.0051
369 SKIN REACTION 72 0.0051
370 EYE SWELLING 188 0.0050
371 CHRONIC KIDNEY DISEASE 383 0.0050
372 ELECTROLYTE IMBALANCE 58 0.0050
373 EYE OPERATION 23 0.0050
374 NEPHROPATHY TOXIC 56 0.0050
375 CATARACT 297 0.0050
376 INTENTIONAL PRODUCT MISUSE 434 0.0050
377 SINUSITIS 508 0.0050
378 PERIORBITAL SWELLING 28 0.0049
379 LEFT VENTRICULAR DYSFUNCTION 33 0.0049
380 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
381 ABNORMAL SENSATION IN EYE 21 0.0049
382 HYPERURICAEMIA 20 0.0049
383 WOUND SECRETION 19 0.0048
384 BLISTER 272 0.0048
385 RESPIRATORY ACIDOSIS 19 0.0048
386 SEASONAL ALLERGY 68 0.0048
387 KNEE ARTHROPLASTY 101 0.0048
388 VENTRICULAR EXTRASYSTOLES 49 0.0047
389 BLOOD COUNT ABNORMAL 71 0.0047
390 INFLAMMATORY MARKER INCREASED 23 0.0046
391 CLOSTRIDIUM DIFFICILE COLITIS 49 0.0046
392 PRESCRIBED UNDERDOSE 92 0.0046
393 BLEPHAROSPASM 29 0.0046
394 AORTIC ANEURYSM 35 0.0046
395 WEIGHT FLUCTUATION 48 0.0046
396 EAR PAIN 89 0.0046
397 SKIN ODOUR ABNORMAL 18 0.0046
398 DISCOMFORT 278 0.0046
399 MULTIPLE ORGAN DYSFUNCTION SYNDROME 129 0.0045
400 MACULOPATHY 16 0.0045
401 INFECTION 647 0.0045
402 HAEMODYNAMIC INSTABILITY 34 0.0045
403 ABSCESS LIMB 19 0.0045
404 PARANASAL SINUS HYPERSECRETION 17 0.0045
405 TENDON RUPTURE 55 0.0045
406 ANAPHYLACTIC REACTION 246 0.0044
407 TUBULOINTERSTITIAL NEPHRITIS 83 0.0044
408 PRODUCT USE ISSUE 829 0.0044
409 PULMONARY EMBOLISM 419 0.0044
410 CARDIOPULMONARY FAILURE 17 0.0044
411 MYOSITIS 39 0.0043
412 HEPATITIS CHOLESTATIC 26 0.0043
413 BODY TEMPERATURE INCREASED 88 0.0043
414 LUNG NEOPLASM MALIGNANT 177 0.0043
415 CHEST PAIN 795 0.0043
416 FACIAL PAIN 38 0.0043
417 HYPERBILIRUBINAEMIA 44 0.0042
418 HERPES ZOSTER 244 0.0042
419 SKIN ABRASION 20 0.0042
420 MOBILITY DECREASED 304 0.0042
421 CONJUNCTIVITIS 78 0.0042
422 PSEUDOMONAS INFECTION 36 0.0042
423 CONJUNCTIVAL HAEMORRHAGE 16 0.0042
424 VENTRICULAR TACHYCARDIA 69 0.0042
425 ORAL CANDIDIASIS 55 0.0042
426 ATELECTASIS 40 0.0041
427 MUSCULOSKELETAL STIFFNESS 362 0.0041
428 DEAFNESS 108 0.0041
429 DELIRIUM 143 0.0041
430 SPINAL STENOSIS 17 0.0041
431 BLOOD PRESSURE DIASTOLIC INCREASED 19 0.0041
432 CHOLELITHIASIS 135 0.0041
433 CONDITION AGGRAVATED 1251 0.0041
434 VOMITING 1926 0.0041
435 MULTIPLE FRACTURES 67 0.0041
436 THROMBOSIS 328 0.0041
437 BLOOD PRESSURE DIASTOLIC DECREASED 30 0.0041
438 INTENTIONAL PRODUCT USE ISSUE 356 0.0041
439 CONCOMITANT DISEASE AGGRAVATED 25 0.0040
440 HYDROCEPHALUS 22 0.0040
441 DYSPNOEA 2284 0.0040
442 PNEUMONIA BACTERIAL 37 0.0040
443 COUGH 1129 0.0040
444 PSORIASIS 524 0.0040
445 ASTHENOPIA 22 0.0040
446 VISION BLURRED 548 0.0040
447 INJURY 279 0.0040
448 TOXIC ENCEPHALOPATHY 20 0.0039
449 TRANSAMINASES INCREASED 87 0.0039
450 SLEEP DISORDER 275 0.0039
451 DYSPNOEA EXERTIONAL 146 0.0039
452 SWELLING 361 0.0039
453 ECONOMIC PROBLEM 58 0.0038
454 PYREXIA 1311 0.0038
455 FREQUENT BOWEL MOVEMENTS 102 0.0038
456 SECRETION DISCHARGE 47 0.0037
457 RESPIRATORY DISORDER 112 0.0037
458 MULTIPLE USE OF SINGLE-USE PRODUCT 21 0.0037
459 BLOOD PRESSURE SYSTOLIC DECREASED 17 0.0037
460 HEPATIC CIRRHOSIS 70 0.0037
461 EAR INFECTION 99 0.0037
462 EAR DISORDER 17 0.0037
463 DISABILITY 73 0.0037
464 TOOTH ABSCESS 37 0.0036
465 RASH 1581 0.0036
466 OSTEOPOROSIS 149 0.0036
467 TACHYPNOEA 49 0.0036
468 NECROSIS 20 0.0036
469 GASTROOESOPHAGEAL REFLUX DISEASE 289 0.0036
470 PNEUMOCYSTIS JIROVECII PNEUMONIA 36 0.0036
471 RENAL TUBULAR NECROSIS 35 0.0036
472 IMMUNOSUPPRESSION 31 0.0035
473 HIDRADENITIS 32 0.0035
474 ILL-DEFINED DISORDER 212 0.0035
475 PRODUCT PRESCRIBING ISSUE 76 0.0035
476 JOINT EFFUSION 24 0.0035
477 ENTEROCOLITIS 20 0.0035
478 PANCYTOPENIA 193 0.0034
479 OEDEMA PERIPHERAL 419 0.0034
480 HALLUCINATION 259 0.0034
481 CANDIDA INFECTION 58 0.0034
482 VAGINAL INFECTION 16 0.0034
483 PHARYNGITIS 42 0.0034
484 MIGRAINE 323 0.0034
485 HYPOMAGNESAEMIA 47 0.0034
486 GAMMA-GLUTAMYLTRANSFERASE INCREASED 74 0.0033
487 RESPIRATORY TRACT CONGESTION 53 0.0033
488 MYELOSUPPRESSION 120 0.0033
489 LEUKOPENIA 166 0.0033
490 SPINAL OSTEOARTHRITIS 29 0.0033
491 CARDIOMEGALY 40 0.0032
492 DRY MOUTH 261 0.0032
493 EYELID OEDEMA 37 0.0032
494 RESPIRATORY FAILURE 232 0.0032
495 SINUS DISORDER 63 0.0032
496 PROTHROMBIN TIME PROLONGED 19 0.0032
497 URTICARIA 532 0.0032
498 MATERNAL EXPOSURE DURING PREGNANCY 283 0.0032
499 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 28 0.0032
500 DYSPHORIA 16 0.0032
501 CLOSTRIDIUM DIFFICILE INFECTION 69 0.0032
502 RENAL CYST 25 0.0031
503 ACUTE HEPATIC FAILURE 43 0.0031
504 SKIN LACERATION 34 0.0031
505 HAEMATOCRIT DECREASED 62 0.0031
506 STEVENS-JOHNSON SYNDROME 69 0.0031
507 CONTUSION 298 0.0031
508 EYE PRURITUS 104 0.0031
509 HYPOALBUMINAEMIA 24 0.0031
510 ACUTE RESPIRATORY FAILURE 59 0.0031
511 MALAISE 1343 0.0031
512 RETCHING 65 0.0030
513 HEPATITIS 78 0.0030
514 SENSITIVITY TO WEATHER CHANGE 16 0.0030
515 HYPOAESTHESIA 455 0.0030
516 HYPONATRAEMIA 171 0.0030
517 OXYGEN SATURATION DECREASED 170 0.0030
518 AGITATION 222 0.0030
519 RHINORRHOEA 195 0.0030
520 PHOTOPSIA 19 0.0030
521 CARDIAC FAILURE ACUTE 20 0.0030
522 ALANINE AMINOTRANSFERASE INCREASED 184 0.0030
523 ABDOMINAL PAIN UPPER 614 0.0030
524 BLOOD ALKALINE PHOSPHATASE INCREASED 74 0.0030
525 ACUTE KIDNEY INJURY 456 0.0030
526 PRODUCT ADMINISTRATION ERROR 60 0.0030
527 PNEUMOTHORAX 47 0.0030
528 SINUS CONGESTION 40 0.0030
529 ULCER HAEMORRHAGE 20 0.0030
530 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 162 0.0029
531 ANXIETY 834 0.0029
532 VISUAL IMPAIRMENT 362 0.0029
533 PAIN 1793 0.0029
534 GENERAL PHYSICAL HEALTH DETERIORATION 337 0.0029
535 LYMPHOPENIA 41 0.0029
536 PERICARDIAL EFFUSION 67 0.0029
537 TRICUSPID VALVE INCOMPETENCE 23 0.0029
538 PRODUCT USE IN UNAPPROVED INDICATION 717 0.0029
539 DRUG INTERACTION 456 0.0029
540 ABDOMINAL DISCOMFORT 479 0.0029
541 RHINITIS 23 0.0028
542 NASOPHARYNGITIS 524 0.0028
543 HYPOKALAEMIA 131 0.0028
544 OFF LABEL USE 2471 0.0028
545 NEPHROPATHY 26 0.0028
546 CARDIAC FAILURE CONGESTIVE 223 0.0028
547 EMPHYSEMA 28 0.0028
548 PERIPHERAL SWELLING 427 0.0028
549 OSTEOMYELITIS 50 0.0028
550 PERIPHERAL SENSORY NEUROPATHY 16 0.0027
551 HEPATIC FUNCTION ABNORMAL 102 0.0027
552 PNEUMONITIS 74 0.0027
553 COVID-19 PNEUMONIA 32 0.0027
554 DECUBITUS ULCER 22 0.0027
555 CHEST DISCOMFORT 276 0.0027
556 WHITE BLOOD CELL COUNT INCREASED 103 0.0027
557 BACTERIAL INFECTION 50 0.0027
558 ELECTROCARDIOGRAM ABNORMAL 21 0.0027
559 GASTROENTERITIS 39 0.0027
560 BLOOD MAGNESIUM DECREASED 23 0.0027
561 ENTERITIS 17 0.0027
562 COAGULOPATHY 44 0.0026
563 PARAESTHESIA 415 0.0026
564 MYOCARDIAL ISCHAEMIA 30 0.0026
565 ASPARTATE AMINOTRANSFERASE INCREASED 140 0.0026
566 MIDDLE INSOMNIA 49 0.0026
567 RESPIRATION ABNORMAL 18 0.0026
568 QUALITY OF LIFE DECREASED 35 0.0026
569 RASH MACULO-PAPULAR 58 0.0026
570 LOCALISED INFECTION 63 0.0026
571 DRUG ERUPTION 46 0.0026
572 EYE DISORDER 85 0.0026
573 CARDIAC FAILURE 207 0.0026
574 RENAL FAILURE 342 0.0026
575 JOINT INJURY 55 0.0026
576 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 20 0.0026
577 LUNG INFECTION 40 0.0026
578 BLOOD SODIUM DECREASED 48 0.0025
579 BACTERAEMIA 30 0.0025
580 NERVE INJURY 28 0.0025
581 SCAR 43 0.0025
582 NEUROTOXICITY 44 0.0025
583 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 43 0.0025
584 OROPHARYNGEAL PAIN 232 0.0025
585 ABDOMINAL PAIN 582 0.0025
586 LUNG INFILTRATION 22 0.0025
587 DERMATITIS BULLOUS 18 0.0025
588 HERNIA 48 0.0025
589 ARTHRITIS 194 0.0025
590 FACIAL PARALYSIS 21 0.0025
591 ENCEPHALITIS 17 0.0025
592 CONFUSIONAL STATE 396 0.0024
593 RED BLOOD CELL COUNT DECREASED 70 0.0024
594 ANAL INCONTINENCE 22 0.0024
595 LYMPHADENOPATHY 86 0.0024
596 PULMONARY CONGESTION 32 0.0024
597 STAPHYLOCOCCAL INFECTION 80 0.0024
598 SKIN MASS 16 0.0024
599 BLOOD ALBUMIN DECREASED 19 0.0024
600 HIATUS HERNIA 31 0.0024
601 DIVERTICULUM 17 0.0024
602 DERMATITIS ALLERGIC 30 0.0024
603 ATRIAL FLUTTER 19 0.0024
604 DRUG USE DISORDER 20 0.0024
605 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
606 DRUG LEVEL DECREASED 24 0.0024
607 VISUAL FIELD DEFECT 17 0.0024
608 IMMUNE SYSTEM DISORDER 31 0.0023
609 MENTAL DISORDER 102 0.0023
610 GASTROINTESTINAL INFECTION 21 0.0023
611 HEPATOMEGALY 23 0.0023
612 BODY TEMPERATURE DECREASED 23 0.0023
613 THYROID DISORDER 36 0.0023
614 CONCUSSION 18 0.0023
615 ANHEDONIA 61 0.0023
616 LYMPHOCYTE COUNT DECREASED 41 0.0023
617 RESPIRATORY DISTRESS 64 0.0023
618 VIRAL INFECTION 77 0.0023
619 BRONCHOSPASM 33 0.0023
620 BLOOD CALCIUM DECREASED 26 0.0023
621 FEBRILE NEUTROPENIA 153 0.0023
622 CONSTIPATION 502 0.0023
623 SEPTIC SHOCK 100 0.0023
624 MITRAL VALVE INCOMPETENCE 26 0.0023
625 CYTOPENIA 28 0.0023
626 BLOOD IRON DECREASED 27 0.0023
627 DEPRESSION 516 0.0023
628 MEDICATION ERROR 126 0.0023
629 DRY EYE 113 0.0023
630 MYDRIASIS 29 0.0023
631 ABSCESS 36 0.0023
632 RENAL INJURY 67 0.0023
633 NEUTROPHIL COUNT INCREASED 23 0.0022
634 INTERNATIONAL NORMALISED RATIO INCREASED 64 0.0022
635 EAR DISCOMFORT 23 0.0022
636 MUSCLE DISORDER 18 0.0022
637 GASTRIC DISORDER 75 0.0022
638 ANAPHYLACTIC SHOCK 56 0.0022
639 BLINDNESS TRANSIENT 16 0.0022
640 BACK DISORDER 35 0.0022
641 HAEMOGLOBIN DECREASED 221 0.0022
642 MALNUTRITION 24 0.0021
643 DECREASED APPETITE 497 0.0021
644 LIMB INJURY 58 0.0021
645 HEPATIC FAILURE 64 0.0021
646 THERAPY PARTIAL RESPONDER 33 0.0021
647 NEURALGIA 51 0.0021
648 BLINDNESS 85 0.0021
649 MYOPATHY 18 0.0021
650 ERYTHEMA 427 0.0021
651 NASAL CONGESTION 122 0.0021
652 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
653 PHOTOSENSITIVITY REACTION 34 0.0021
654 IRON DEFICIENCY ANAEMIA 19 0.0021
655 GENERALISED TONIC-CLONIC SEIZURE 34 0.0021
656 HEART RATE DECREASED 72 0.0020
657 ARTHRALGIA 852 0.0020
658 OVERDOSE 442 0.0020
659 ANAEMIA 390 0.0020
660 SKIN LESION 56 0.0020
661 BLOOD POTASSIUM DECREASED 61 0.0020
662 EYE HAEMORRHAGE 27 0.0020
663 MENTAL IMPAIRMENT 49 0.0020
664 MACULAR DEGENERATION 24 0.0020
665 PAIN IN EXTREMITY 592 0.0020
666 HAEMOLYTIC ANAEMIA 18 0.0020
667 JAUNDICE 54 0.0020
668 HEADACHE 1257 0.0020
669 OROPHARYNGEAL DISCOMFORT 18 0.0020
670 SKIN EXFOLIATION 168 0.0020
671 RENAL IMPAIRMENT 167 0.0020
672 SUDDEN DEATH 21 0.0020
673 STENT PLACEMENT 16 0.0020
674 MUSCLE SPASMS 364 0.0020
675 MUSCULOSKELETAL DISCOMFORT 34 0.0020
676 SINUS TACHYCARDIA 28 0.0020
677 COLITIS ULCERATIVE 88 0.0020
678 SKIN INFECTION 22 0.0020
679 BACK PAIN 455 0.0020
680 PHARYNGEAL OEDEMA 30 0.0019
681 DIVERTICULITIS 54 0.0019
682 DEVICE USE ISSUE 34 0.0019
683 PHARYNGEAL SWELLING 19 0.0019
684 HEART RATE INCREASED 192 0.0019
685 ERYTHEMA MULTIFORME 18 0.0019
686 PANCREATITIS 102 0.0019
687 DIARRHOEA HAEMORRHAGIC 18 0.0019
688 PLEURAL EFFUSION 117 0.0019
689 PURPURA 17 0.0019
690 TENDERNESS 20 0.0019
691 FATIGUE 1494 0.0019
692 DISSEMINATED INTRAVASCULAR COAGULATION 27 0.0019
693 WEIGHT INCREASED 429 0.0019
694 RESPIRATORY RATE INCREASED 17 0.0019
695 BLOOD UREA INCREASED 32 0.0019
696 PLATELET COUNT DECREASED 202 0.0019
697 HEMIPARESIS 32 0.0019
698 DIPLOPIA 49 0.0019
699 CIRCULATORY COLLAPSE 32 0.0019
700 UNDERDOSE 137 0.0019
701 MUSCLE SPASTICITY 23 0.0019
702 PRODUCT CONTAINER ISSUE 16 0.0019
703 APHONIA 26 0.0019
704 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
705 LEUKOCYTOSIS 33 0.0018
706 POST PROCEDURAL COMPLICATION 35 0.0018
707 LIGAMENT SPRAIN 18 0.0018
708 ARRHYTHMIA 86 0.0018
709 TREATMENT NONCOMPLIANCE 99 0.0018
710 HEPATIC CYTOLYSIS 23 0.0018
711 HYPERTHYROIDISM 26 0.0018
712 ALOPECIA 351 0.0018
713 TOXIC SKIN ERUPTION 18 0.0018
714 PERITONITIS BACTERIAL 18 0.0018
715 SNEEZING 40 0.0018
716 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
717 DYSPEPSIA 174 0.0018
718 TACHYCARDIA 157 0.0018
719 DIARRHOEA 1137 0.0018
720 GAIT DISTURBANCE 336 0.0018
721 JOINT STIFFNESS 46 0.0018
722 INFLUENZA 195 0.0017
723 HYPOACUSIS 75 0.0017
724 DISEASE PROGRESSION 206 0.0017
725 FUNGAL INFECTION 58 0.0017
726 BLOOD THYROID STIMULATING HORMONE INCREASED 16 0.0017
727 AMNESIA 113 0.0017
728 PRURITUS 664 0.0017
729 ANGIOEDEMA 76 0.0017
730 VENTRICULAR FIBRILLATION 19 0.0017
731 ASTHENIA 643 0.0017
732 BLOOD PRESSURE FLUCTUATION 41 0.0017
733 FLANK PAIN 16 0.0017
734 ATRIAL FIBRILLATION 166 0.0017
735 ASCITES 50 0.0017
736 SHOCK 39 0.0017
737 CYTOKINE RELEASE SYNDROME 34 0.0017
738 HEPATOCELLULAR INJURY 24 0.0017
739 SPINAL DISORDER 16 0.0017
740 ATAXIA 20 0.0017
741 MUSCULAR WEAKNESS 188 0.0017
742 BLOOD CREATININE INCREASED 108 0.0017
743 PRODUCT USE COMPLAINT 26 0.0016
744 HYPOCALCAEMIA 31 0.0016
745 DRUG INEFFECTIVE 2151 0.0016
746 RECTAL HAEMORRHAGE 70 0.0016
747 LABORATORY TEST ABNORMAL 48 0.0016
748 DEVICE RELATED INFECTION 25 0.0016
749 SENSORY DISTURBANCE 26 0.0016
750 NEUTROPENIA 220 0.0016
751 NAUSEA 1279 0.0016
752 INCORRECT PRODUCT ADMINISTRATION DURATION 35 0.0016
753 CHOLESTASIS 31 0.0016
754 DIZZINESS 805 0.0016
755 MYALGIA 273 0.0016
756 TOOTHACHE 29 0.0016
757 FEELING HOT 98 0.0016
758 DISEASE RECURRENCE 76 0.0016
759 CELLULITIS 80 0.0016
760 BRAIN OEDEMA 20 0.0016
761 DRUG LEVEL INCREASED 26 0.0016
762 ADVERSE DRUG REACTION 141 0.0016
763 CYTOMEGALOVIRUS INFECTION 26 0.0016
764 GASTRITIS 41 0.0016
765 PANCREATITIS ACUTE 35 0.0016
766 TEMPERATURE INTOLERANCE 16 0.0015
767 HEART RATE IRREGULAR 35 0.0015
768 GASTROINTESTINAL PAIN 17 0.0015
769 BLOOD PRESSURE INCREASED 236 0.0015
770 PALPITATIONS 180 0.0015
771 PULMONARY HYPERTENSION 32 0.0015
772 SEPSIS 171 0.0015
773 POOR QUALITY SLEEP 33 0.0015
774 OSTEOPENIA 23 0.0015
775 FISTULA 17 0.0015
776 HYPERKALAEMIA 53 0.0015
777 FEELING COLD 42 0.0015
778 RIB FRACTURE 31 0.0015
779 MASS 21 0.0015
780 MUSCLE ATROPHY 19 0.0015
781 CARDIOMYOPATHY 22 0.0015
782 WEIGHT DECREASED 415 0.0015
783 MUSCULOSKELETAL CHEST PAIN 23 0.0015
784 TASTE DISORDER 30 0.0015
785 HALLUCINATION, VISUAL 31 0.0015
786 ANGINA PECTORIS 42 0.0015
787 SPLENOMEGALY 17 0.0014
788 HYPOPHAGIA 37 0.0014
789 WHITE BLOOD CELL COUNT DECREASED 156 0.0014
790 DEEP VEIN THROMBOSIS 93 0.0014
791 HYPERSOMNIA 41 0.0014
792 FRACTURE 27 0.0014
793 NEUTROPHIL COUNT DECREASED 58 0.0014
794 HYPERLIPIDAEMIA 17 0.0014
795 LIMB DISCOMFORT 44 0.0014
796 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
797 EPILEPSY 43 0.0014
798 LIVER FUNCTION TEST INCREASED 30 0.0014
799 INSOMNIA 370 0.0014
800 CORONARY ARTERY DISEASE 42 0.0014
801 HAEMORRHOIDS 27 0.0014
802 MUCOSAL INFLAMMATION 36 0.0014
803 ABDOMINAL DISTENSION 143 0.0014
804 MENTAL STATUS CHANGES 38 0.0014
805 PULMONARY OEDEMA 61 0.0014
806 ADVERSE EVENT 125 0.0014
807 DYSARTHRIA 51 0.0014
808 SKIN ULCER 35 0.0014
809 METABOLIC ACIDOSIS 43 0.0013
810 BLOOD PRESSURE DECREASED 89 0.0013
811 DYSPHONIA 78 0.0013
812 BONE MARROW FAILURE 27 0.0013
813 FEMUR FRACTURE 41 0.0013
814 SWELLING FACE 86 0.0013
815 FOOT FRACTURE 25 0.0013
816 PARAESTHESIA ORAL 19 0.0013
817 BONE DISORDER 24 0.0013
818 CEREBRAL INFARCTION 32 0.0013
819 VERTIGO 79 0.0013
820 CARDIAC ARREST 107 0.0013
821 RASH PRURITIC 70 0.0013
822 CYST 16 0.0013
823 THERAPY INTERRUPTED 92 0.0013
824 EJECTION FRACTION DECREASED 20 0.0013
825 GOUT 23 0.0013
826 MYOCARDIAL INFARCTION 222 0.0013
827 PAIN IN JAW 36 0.0013
828 LACTIC ACIDOSIS 41 0.0013
829 FEAR 34 0.0013
830 ORTHOSTATIC HYPOTENSION 22 0.0013
831 LIP SWELLING 42 0.0013
832 HYPOAESTHESIA ORAL 19 0.0013
833 UPPER GASTROINTESTINAL HAEMORRHAGE 21 0.0012
834 FACE OEDEMA 21 0.0012
835 TOXICITY TO VARIOUS AGENTS 209 0.0012
836 FLUID OVERLOAD 18 0.0012
837 HAEMATOMA 32 0.0012
838 PRESYNCOPE 30 0.0012
839 HYPOTENSION 247 0.0012
840 IMPAIRED WORK ABILITY 26 0.0012
841 DISTURBANCE IN ATTENTION 65 0.0012
842 FEELING ABNORMAL 288 0.0012
843 SPEECH DISORDER 62 0.0012
844 ENCEPHALOPATHY 29 0.0012
845 HYPERGLYCAEMIA 43 0.0012
846 INTERSTITIAL LUNG DISEASE 57 0.0012
847 THERAPEUTIC RESPONSE SHORTENED 39 0.0012
848 IMPAIRED GASTRIC EMPTYING 16 0.0012
849 DYSPHAGIA 111 0.0012
850 GASTROENTERITIS VIRAL 21 0.0012
851 DISORIENTATION 46 0.0012
852 PNEUMONIA ASPIRATION 29 0.0012
853 MULTI-ORGAN FAILURE 20 0.0012
854 BLOOD PRESSURE ABNORMAL 23 0.0012
855 RENAL FAILURE ACUTE 49 0.0012
856 DIABETES MELLITUS 88 0.0012
857 DEPRESSED MOOD 61 0.0012
858 CHROMATURIA 26 0.0012
859 SYNCOPE 114 0.0011
860 EPISTAXIS 85 0.0011
861 PRODUCT PRESCRIBING ERROR 27 0.0011
862 NIGHTMARE 39 0.0011
863 OSTEONECROSIS 37 0.0011
864 GASTROINTESTINAL HAEMORRHAGE 94 0.0011
865 NERVOUS SYSTEM DISORDER 35 0.0011
866 GALLBLADDER DISORDER 20 0.0011
867 CHILLS 131 0.0011
868 TREMOR 185 0.0011
869 IMPAIRED QUALITY OF LIFE 16 0.0011
870 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
871 HOSPITALISATION 170 0.0011
872 PELVIC PAIN 20 0.0011
873 LIVER FUNCTION TEST ABNORMAL 32 0.0011
874 URINARY TRACT INFECTION 187 0.0011
875 SEROTONIN SYNDROME 21 0.0011
876 BASAL CELL CARCINOMA 17 0.0011
877 RHABDOMYOLYSIS 45 0.0011
878 FALL 358 0.0011
879 NECK PAIN 60 0.0011
880 HALLUCINATION, AUDITORY 17 0.0011
881 THROAT IRRITATION 48 0.0011
882 CARDIAC DISORDER 99 0.0011
883 BURNING SENSATION 74 0.0011
884 PROTEINURIA 20 0.0011
885 PANIC ATTACK 38 0.0010
886 AGEUSIA 26 0.0010
887 ACUTE MYELOID LEUKAEMIA 16 0.0010
888 ORAL HERPES 20 0.0010
889 CARDIOVASCULAR DISORDER 26 0.0010
890 HAEMATURIA 35 0.0010
891 MEMORY IMPAIRMENT 140 0.0010
892 PRODUCT DOSE OMISSION ISSUE 298 0.0010
893 OSTEONECROSIS OF JAW 25 0.0010
894 DYSKINESIA 41 0.0010
895 BLOOD URINE PRESENT 19 0.0010
896 BRADYCARDIA 53 0.0010
897 FOETAL EXPOSURE DURING PREGNANCY 80 0.0010
898 SWOLLEN TONGUE 30 0.0010
899 ACCIDENTAL OVERDOSE 35 0.0010
900 PALLOR 26 0.0010
901 EATING DISORDER 20 0.0009
902 FLATULENCE 53 0.0009
903 PLASMA CELL MYELOMA 36 0.0009
904 ABDOMINAL PAIN LOWER 23 0.0009
905 BLOOD CREATINE PHOSPHOKINASE INCREASED 26 0.0009
906 RESTLESSNESS 33 0.0009
907 APHASIA 27 0.0009
908 MOVEMENT DISORDER 28 0.0009
909 BALANCE DISORDER 75 0.0009
910 CARDIO-RESPIRATORY ARREST 36 0.0009
911 AGRANULOCYTOSIS 16 0.0009
912 COVID-19 150 0.0009
913 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
914 NEPHROLITHIASIS 39 0.0008
915 SEIZURE 97 0.0008
916 FEEDING DISORDER 17 0.0008
917 RENAL DISORDER 39 0.0008
918 SUICIDAL IDEATION 76 0.0008
919 ILLNESS 85 0.0008
920 DEHYDRATION 110 0.0008
921 MUSCLE TWITCHING 19 0.0008
922 DYSSTASIA 24 0.0008
923 HEAD INJURY 26 0.0008
924 BONE PAIN 48 0.0008
925 EMOTIONAL DISTRESS 99 0.0008
926 DYSGEUSIA 60 0.0008
927 SKIN DISCOLOURATION 37 0.0008
928 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 145 0.0008
929 FULL BLOOD COUNT DECREASED 16 0.0008
930 SOMNOLENCE 159 0.0008
931 DYSURIA 29 0.0008
932 HAEMATOCHEZIA 43 0.0008
933 HYPOGLYCAEMIA 37 0.0008
934 PRURITUS GENERALISED 16 0.0007
935 UNRESPONSIVE TO STIMULI 19 0.0007
936 LETHARGY 41 0.0007
937 ACUTE MYOCARDIAL INFARCTION 21 0.0007
938 LOSS OF CONSCIOUSNESS 91 0.0007
939 ABNORMAL BEHAVIOUR 28 0.0007
940 PREMATURE BABY 21 0.0007
941 THERAPEUTIC RESPONSE DECREASED 42 0.0007
942 BLOOD GLUCOSE INCREASED 130 0.0007
943 URINARY INCONTINENCE 20 0.0007
944 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
945 NERVOUSNESS 35 0.0007
946 PAIN OF SKIN 18 0.0007
947 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 135 0.0007
948 NEOPLASM PROGRESSION 23 0.0007
949 EXTRAPYRAMIDAL DISORDER 16 0.0006
950 SKIN DISORDER 21 0.0006
951 INTESTINAL OBSTRUCTION 23 0.0006
952 DEMENTIA 17 0.0006
953 COLITIS 23 0.0006
954 RASH MACULAR 21 0.0006
955 DEATH 512 0.0006
956 COMA 28 0.0006
957 MALIGNANT NEOPLASM PROGRESSION 60 0.0006
958 THERAPY CESSATION 30 0.0006
959 CEREBRAL HAEMORRHAGE 20 0.0006
960 HAEMORRHAGE 58 0.0006
961 HOT FLUSH 41 0.0005
962 URINARY RETENTION 18 0.0005
963 COGNITIVE DISORDER 25 0.0005
964 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
965 CRYING 18 0.0005
966 INFLUENZA LIKE ILLNESS 40 0.0005
967 DRY SKIN 62 0.0005
968 CEREBROVASCULAR ACCIDENT 78 0.0005
969 NO ADVERSE EVENT 82 0.0005
970 FLUSHING 43 0.0004
971 AGGRESSION 21 0.0004
972 BREAST CANCER 39 0.0004
973 IRRITABILITY 25 0.0004
974 CONVULSION 23 0.0004
975 ABORTION SPONTANEOUS 16 0.0004
976 UNEVALUABLE EVENT 29 0.0004
977 PRODUCT QUALITY ISSUE 52 0.0004
978 NEOPLASM MALIGNANT 25 0.0004
979 INCORRECT DOSE ADMINISTERED 85 0.0004
980 SURGERY 20 0.0003
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 24 0.0003
982 PRODUCT DOSE OMISSION 18 0.0003
983 INJECTION SITE BRUISING 21 0.0003
984 INJECTION SITE HAEMORRHAGE 19 0.0002
985 ACNE 18 0.0002
986 PRODUCT STORAGE ERROR 20 0.0002
987 INJECTION SITE SWELLING 17 0.0002
988 INJECTION SITE PAIN 64 0.0002
989 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
990 DRUG DEPENDENCE 29 0.0002
991 INJECTION SITE ERYTHEMA 17 0.0001
992 DRUG DOSE OMISSION 21 0.0001